The Dietitians Association of Australia (DAA) warns that focusing solely on reducing trans fats could actually increase the amount of dangerous saturated fats in the Australian food supply.
More than 600 school nutrition professionals will call on Congress to adopt national school food and beverage standards for ?competitive foods? sold on school campuses.
Despite the potential for conflict of interest, virtually all practicing physicians in the U.S. have some form of relationship with pharmaceutical manufacturers but the nature and extent of those relationships vary, depending on the kind of practice, medical specialty, patient mix, and professional activities, reports a study in the April 26 issue of the New England Journal of Medicine.
The U.S. Department of Agriculture (USDA) and the U.S. Food and Drug Administration (FDA) continue their investigation of imported rice protein concentrate which has been found to contain melamine and melamine-related compounds.
With the increasing proportion of the seafood being farmed in captivity worldwide, the United Nations is working to create a new international standard to certify the safety and harvesting of fish.
The Food Standards Agency has today been informed that Morrisons is withdrawing packs of its own brand pre-packed leaf salad because of possible salmonella contamination.
Community Foods Ltd is recalling a batch of Nature?s Path ?gluten free? Organic Mesa Sunrise Flakes breakfast cereal (300g box) because the food contains high levels of gluten. This makes it unsafe for people who are intolerant to gluten – gluten allergy. The Food Standards Agency has issued an Allergy Alert.
The USDA Food Safety and Inspection Service (FSIS) and the U.S. Food and Drug Administration (FDA) notified State authorities that swine fed adulterated product will not be approved to enter the food supply.
National Osteoporosis Month is right around the corner, reminding most health professionals to counsel their clients about the bone-building benefits of calcium and vitamin D.
Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.